Abstract
27 reprogramming)(2) in response to transcription factor over--expression . To explore  28 what makes a cell plastic and whether these different cell conversion processes are 29 coupled, we exposed bone marrow derived pre--B cells to two different transcription 30 factor overexpression protocols that efficiently convert them either into macrophages 31 or iPSCs and monitored the two processes over time using single cell gene expression 32 analysis. We found that even in these highly efficient cell fate conversion systems, 33 cells differ in both their speed and path of transdifferentiation and reprogramming. 34
This heterogeneity originates in two starting pre--B cell subpopulations, large pre--BII 35 and the small pre--BII cells they normally differentiate into. The large cells 36 transdifferentiate slowly but exhibit a high efficiency of iPSC reprogramming. In 37 contrast, the small cells transdifferentiate rapidly but are highly resistant to 38 reprogramming. Moreover, the large B cells induce a stronger transient 39 granulocyte/macrophage progenitor (GMP)--like state, while the small B cells undergo a 40 more direct conversion to the macrophage fate. The large cells are cycling and exhibit 41 high Myc activity whereas the small cells are Myc low and mostly quiescent. The 42 observed heterogeneity of the two cell conversion processes can therefore be traced 43 to two closely related cell types in the starting population that exhibit different types 44 of plasticity. These data show that a somatic cell's propensity for either 45 transdifferentiation and reprogramming can be uncoupled. 46 macrophage programs). We found that a signature highly enriched in Myc target genes 94 (component 5, Fig. S2 , Table S4 ) best predicts and negatively correlates with the extent 95 of transdifferentiation at intermediate time points (Fig.  2B,  Fig.  S5 ). Expression of the 96
Myc targets varies extensively across cells within each time point but changes little 97 during transdifferentiation (Fig. 2C) . The data therefore suggest that the cells with 98 lower expression of Myc targets transdifferentiate more rapidly into macrophages. 99 100
We next tested how the expression of Myc targets relates to the loss of the B cell state 101 and the acquisition of transient myeloid--like cell states during transdifferentiation. 102
Visualizing similarity to the pre--B cell state shows that low expression of Myc targets is 103 more strongly associated with a rapid gain of the macrophage state than with a rapid 104 loss of the B cell state (Fig.  2D) . Moreover, higher Myc target expression is associated 105 with a larger and more persistent induction of a GMP--like state (Fig.  2E) . Myc target 106 expression does not associate with the extent of induction of a transient monocyte--107 (Fig.  2F ) or granulocyte--like state (Fig.  S6 ). S9D, S10D). In stark contrast, when 18h pulsed cells (also designated 'Ba cells'(4, 6)) 169 were tested for reprogramming in response to OSKM induction, large pre--BII cells 170 generated 30x times more iPSC colonies than small pre--B cells (Figs. 3H--I). Previous 171 work has shown that C/EBPa induced maximal reprogramming efficiency by 18hrs of 172 treatment, after which it decreases again(4), raising the possibility that an accelerated 173 transdifferentiation of the small cells towards macrophages moves them out of the 174 time window of highest responsiveness. We therefore tested the effect of a shorter 175 pulse of C/EBPa (6h) and found that the small cells were still highly resistant to 176 reprogramming, with an 18h pulse still producing a slight increase in the number of 177 iPSC colonies (Fig. S9E ). This result indicates that the two cell types exhibit intrinsic 178 differences in their cell conversion preferences. 179 180
We next asked whether the Myc signature also predicts the reprogramming efficiency 181 of other somatic cells, examining existing datasets of 20 hematopoietic and non--182 hematopoietic cell types(2, 17--20 We used 'reprogrammable mice' containing a doxycycline--inducible OSKM cassette 385 and the tetracycline transactivator(5). CD19 + pre--B cells were isolated from the bone 386 marrow of these mice using monoclonal antibody to CD19 (clone 1D3, BD Pharmingen 387 #553784) and MACS sorting (Miltenyi Biotech). Cell purity was confirmed to be >98% 388 CD19+ by FACS using an LSRII machine (BD). After isolation, B cells were grown in RPMI 389 medium supplemented with 10% FBS and 10ng/ml IL--7 (Peprotech), L--glutamine, 390 nonessential amino acids, β--mercaptoethanol (Life Technologies) as well as 391 penicillin/streptomycin. Mouse embryo fibroblasts (MEFs) were isolated from E13. Reconstruction of gene expression after filtering out components capturing batch 597 effects. 598 Table S1 . Gene cluster membership and gene loadings on each independent 658 component for each detected gene. The sign of cluster membership is positive if the 659 gene has the highest absolute loading on the positive side of the component and 660 negative if the highest absolute loading is on the negative side of the component. 661 Table S2 . Total mRNA count, number of detected genes, and projection onto each 662 independent component, for each single cell. 663 Table S3 . Fisher's test based gene set enrichment analysis on Gene Ontology 664 categories (biological process) for each gene cluster. Includes odds ratios, p--values and 665 FDR, number of genes associated to each category, number and names of genes 666 included both in the cluster and in the category. 667 Table S4 . Fisher's test based gene set enrichment analysis on hallmark genesets for 668 each gene cluster. Includes odds ratio, p--value and FDR, number of genes included in 669 each category, number and names of genes both included both in the cluster and in 670 the category. 671
